Charles A Rowland Jr Insider Trading $BPMC Blueprint Medicines Corp
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Charles A Rowland Jr.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Charles A Rowland Jr. Charles A Rowland Jr is EVP, CFO & Treasurer in ENDO HEALTH SOLUTIONS INC. ($ENDP) and Director in Vitae Pharmaceuticals, Inc ($VTAE) and Director in BIND Therapeutics, Inc ($BIND) and Director in Blueprint Medicines Corp ($BPMC) and Director in Viking Therapeutics, Inc. ($VKTX) and Director in Nabriva Therapeutics plc ($NBRV) and Director in Nabriva Therapeutics Plc ($NBRV) and in Generation Bio Co. ($GBIO) and Director in Generation Bio Co. ($GBIO) and Director in Orchard Therapeutics plc ($ORTX).
Charles A Rowland Jr in Blueprint Medicines Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Charles A Rowland Jr: Director
Holdings: 14,471 shares
Current Value: $518,641
Latest Transaction: Dec 18 2020
$BPMC Market Capitalization: $979.55M
$BPMC Previous Close: $35.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Charles A Rowland Jr in Blueprint Medicines Corp
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, BPMC, BIND, ENDP, GBIO, NBRV, NBRV, ORTX, VKTX, VTAE
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 19.53 | 10,909 | 213,053 | 0 | |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 117.82 | 10,909 | 1,285,298 | 3,562 | 14.5 K to 3.6 K (-75.39 %) |
| Dec 18 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 19.53 | 10,909 | 213,053 | 14,471 | 3.6 K to 14.5 K (+306.26 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 9.46 | 5,522 | 52,238 | 0 | |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 9.46 | 4,478 | 42,362 | 5,522 | |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 95.97 | 694 | 66,603 | 3,562 | 4.3 K to 3.6 K (-16.31 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 99.10 | 4,728 | 468,545 | 4,256 | 9 K to 4.3 K (-52.63 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 100.48 | 100 | 10,048 | 8,984 | 9.1 K to 9 K (-1.10 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 9.46 | 5,522 | 52,238 | 9,084 | 3.6 K to 9.1 K (+155.03 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 99.11 | 4,478 | 443,815 | 3,562 | 8 K to 3.6 K (-55.70 %) |
| Nov 04 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 9.46 | 4,478 | 42,362 | 8,040 | 3.6 K to 8 K (+125.72 %) |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 76.24 | 4,500 | 343,080 | 4,500 | |
| Jun 26 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Grant | A | 0.00 | 2,250 | 0 | 3,562 | 1.3 K to 3.6 K (+171.49 %) |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 0.00 | 1,312 | 0 | 0 | |
| Jun 23 2020 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 0.00 | 1,312 | 0 | 1,312 | 0 to 1.3 K |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | M | 9.46 | 11,818 | 111,798 | 10,000 | |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 94.83 | 9,271 | 879,169 | 0 | 9.3 K to 0 (-100.00 %) |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 96.08 | 1,600 | 153,728 | 9,271 | 10.9 K to 9.3 K (-14.72 %) |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Sell | S | 96.69 | 947 | 91,565 | 10,871 | 11.8 K to 10.9 K (-8.01 %) |
| Jun 24 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Buy | M | 9.46 | 11,818 | 111,798 | 11,818 | 0 to 11.8 K |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 0.00 | 1,312 | 0 | 1,312 | |
| Jun 20 2019 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 96.77 | 4,875 | 471,754 | 4,875 | |
| Jun 25 2018 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 69.79 | 7,500 | 523,425 | 51,136 | |
| Jun 23 2017 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 46.02 | 10,909 | 502,032 | 43,636 | |
| Jun 27 2016 | BPMC | Blueprint Medicine ... | Rowland Charles A Jr | Director | Option Exercise | A | 19.53 | 10,909 | 213,053 | 32,727 |
Page: 1